Niagen Bioscience: Detailed Company Information & Corporate Profile
Summary
Niagen Bioscience was founded in 1999 and is headquartered in Los Angeles, California. The independent company employs between 100 and 200 people and reports annual revenues ranging from $50 million to $100 million. It specializes in NAD+ research, cellular health, nutraceuticals, dietary supplements, pharmaceutical‑grade ingredients, reference standards, ingredient technologies, product innovation, and related bioscience services.
Niagen provides regulatory and safety consulting, clinical research, research partnerships, patent development, metabolic health support, and expertise in NAD+ precursors. Its work supports both academic and commercial projects focused on cellular biology and metabolic pathways.
The leadership team includes Co‑Founder and CEO Frank Jaksch, Senior Vice President of General Counsel Carlos Lopez, Chief Financial Officer Mary Zhou, Vice President of R&D Aron Erickson, Director of Finance Myron Krochak, Senior Director of Supply Chain and Operations Elizabeth Maravilla, Head of E‑commerce DTC Marketing Derrick, and other specialists such as Sales Development Specialist HCP Batel Ouda, Senior Business Consultant Helen Medina, Procurement Specialist Susan Nguyen, Payroll Manager Thida Kim, Accounting Supervisor Kate, and Consultant Yasmeen Nkrumah.
| Niagen Bioscience Website | niagenbioscience.com |
| Social Links |    |
| Phone Number | +1 310 388 6706 |
| Industries | |
| Niagen Bioscience Headquarters Address | 10900 Wilshire Blvd, Los Angeles, California, 92618 US |
| Company Size | 100-200 employees |
| Specialities & Services | Reference Standards, Consumer Products, Ingredient Technologies, Product Innovation, Regulatory and Safety Consulting, Clinical Research, Research Partnerships, NAD+ Research, Cellular Health, Nutraceuticals, Dietary Supplements, Pharmaceutical-Grade Ingredients, NAD+ Precursors, Patent Development, Metabolic Health, Bioscience Research |
| SIC Code | 2810, 8734 |
| NAICS Code | 541380 Testing Laboratories, 541940 Veterinary Services |
| DMA Code | Los Angeles Metropolitan Area |
| Founded | 1999 |
| Estimated Annual Revenue | $50M - 100M |
| Operating Status | Independent Company |
| Updated: | 2026-09-21 |
Niagen Bioscience Org Chart
Chief Executive Officer
C-Level
Chief Marketing Officer
Chief Financial Officer
Chief Financial Officer
Competitors
Name | Founded | Type | Employees |
|---|---|---|---|
| 2017 | Public Company | 25 - 100 | |
| 2014 | Privately Held | 25 - 100 | |
| 1992 | Privately Held | 1.0K - 5.0K | |
| 1921 | Privately Held | 500 - 1.0K |
Estimated Website Traffic
The chart shows a decline in traffic to the niagenbioscience.com website. In September, traffic decreased to 6703, compared to 7255 in the previous month. The highest traffic in 2026 was recorded in January, reaching 10521 visits.
Workforce Turnover
Number of employees switched from or switched to
Departmental sample breakdown
Length of Employment
Niagen Bioscience's workforce includes employees across a wide range of tenure levels.
10% have been with the company for less than 1 year7% have been with the company for 1 to 2 years7% have been with the company for 3 to 4 years20% have been with the company for 5 to 7 years17% have been with the company for 8 to 10 years40% have been with the company for more than 11 years
Companies Similar to Niagen Bioscience
Niagen Bioscience Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
